The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro

被引：0
|
作者：
Ashraf Khalil
Mark J. Jameson
机构：
[1] University of Virginia Health System,Division of Head and Neck Oncologic and Microvascular Surgery, Department of Otolaryngology
[2] Menoufiya University,Head and Neck Surgery
来源：
Drugs in R&D | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：545 / 555
页数：10
相关论文
共 50 条
  • [1] The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro
    Khalil, Ashraf
    Jameson, Mark J.
    [J]. DRUGS IN R&D, 2017, 17 (04) : 545 - 555
  • [2] EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines
    Hiraishi, Yukihiro
    Wada, Takeshi
    Nakatani, Ken
    Tojyo, Itaru
    Matsumoto, Takashi
    Kiga, Norifumi
    Negoro, Kenji
    Fujita, Shigeyuki
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2008, 14 (01) : 39 - 43
  • [3] Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib
    Taguchi, Takahide
    Tsukuda, Mamoru
    Imagawa-Ishiguro, Yukari
    Kato, Yasumasa
    Sano, Daisuke
    [J]. ONCOLOGY REPORTS, 2008, 19 (01) : 65 - 71
  • [4] Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo
    Yasukawa, Masaaki
    Fujihara, Hisako
    Fujimori, Hiroaki
    Kawaguchi, Koji
    Yamada, Hiroyuki
    Nakayama, Ryoko
    Yamamoto, Nanami
    Kishi, Yuta
    Hamada, Yoshiki
    Masutani, Mitsuko
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03)
  • [5] p53-independent apoptosis induced by cisplatin and enhanced by the combination of cisplatin with ZD1839 (Iressa™) an EGFR-TK inhibitor in an oral squamous cell carcinoma cell line.
    Al-Hazzaa, AA
    Bowen, ID
    Birchall, MA
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3723S - 3723S
  • [6] The effects of combination of gefitinib and cisplatin on tongue squamous cell carcinoma cell lines
    Helal, Hussein H. S.
    Qi, Chang E.
    Zhao, Yan Yu
    Yao, Cong Shan
    Li, De Chao
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (01) : 37 - 40
  • [7] A γ-Secretase Inhibitor Attenuates Cell Cycle Progression and Invasion in Human Oral Squamous Cell Carcinoma: An In Vitro Study
    Pongjantarasatian, Sarai
    Nowwarote, Nunthawan
    Rotchanakitamnuai, Varumporn
    Srirodjanakul, Watcharee
    Saehun, Ritmongkol
    Janebodin, Kajohnkiart
    Manokawinchoke, Jeeranan
    Fournier, Benjamin P. J.
    Osathanon, Thanaphum
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [8] Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma
    Ota, Tomoko
    Jono, Hirofumi
    Ota, Kazutoshi
    Shinriki, Satoru
    Ueda, Mitsuharu
    Sueyoshi, Takanao
    Nakatani, Ken
    Hiraishi, Yukihiro
    Wada, Takeshi
    Fujita, Shigeyuki
    Obayashi, Konen
    Shinohara, Masanori
    Ando, Yukio
    [J]. ONCOLOGY REPORTS, 2012, 27 (05) : 1674 - 1680
  • [9] Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM-19
    Li, Minghe
    Li, Zhihong
    Li, Jia
    Jin, Liou
    Jin, Chengxue
    Han, Chengmin
    Ji, Xin
    Sun, Fei
    [J]. MOLECULAR MEDICINE REPORTS, 2015, 12 (06) : 8185 - 8192
  • [10] Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line
    Zhang, Ping
    Zhang, Zhiyuan
    Zhou, Xiaojian
    Qiu, Weiliu
    Chen, Fangan
    Chen, Wantao
    [J]. BMC CANCER, 2006, 6 (1)
12345